72957-37-0,
Gly-His-Lys acetate salt,
Gly-His-Lys acetate,
UNII-8AA809EUS9,
(S)-6-Amino-2-((S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido)hexanoic acid compound with acetic acid (1:1),
8AA809EUS9,
N2-(N-Glycyl-L-histidyl)-L-lysine monoacetate,
Prezatide monoacetate,
MFCD00012699,
Gly-His-Lysacetatesalt,
Gly-His-Lysacetate,
EINECS 277-125-4,
SCHEMBL810924,
AKOS015913925,
AK-48470,
L-Lysine, glycyl-L-histidyl-, monoacetate,
AX8015644,
Gly-His-Lys acetate salt, >=97% (TLC),
FT-0641435,
Liver Cell Growth Factor acetate salt, BT-242,
957G370,
C-21712,
glycyl-L-histidyl-L-lysine compound with acetic acid (1:1),
Gly-His-Lys acetate salt, BioXtra, gamma-irradiated, suitable for cell culture,
Liver cell growth factor,
C14H24N6O4.C2H4O2,
ACN-057291,
Gly-His-Lys acetate salt, 99% - 5G 5g,
C14-H24-N6-O4.C2-H4-O2,
ghk,